Emergence delirium with transient associative agnosia and expressive aphasia reversed by flumazenil in a pediatric patient

Julie K. Drobish, Max B. Kelz, Patricia M. DiPuppo, Scott D. Cook-Sather

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Multiple factors may contribute to the development of emergence delirium in a child. We present the case of a healthy 12-year-old girl who received preoperative midazolam with the desired anxiolytic effect, underwent a brief general anesthetic, and then exhibited postoperative delirium, consisting of a transient associative agnosia and expressive aphasia. Administration of flumazenil led to immediate and lasting resolution of her symptoms. We hypothesize that γ-aminobutyric acid type A receptor-mediated effects, most likely related to an atypical offset of midazolam, are an important subset of emergence delirium that is amenable to pharmacologic therapy with flumazenil.

Original languageEnglish
Pages (from-to)148-150
Number of pages3
JournalA & A case reports
Volume4
Issue number11
DOIs
StatePublished - Jun 1 2015

Fingerprint

Dive into the research topics of 'Emergence delirium with transient associative agnosia and expressive aphasia reversed by flumazenil in a pediatric patient'. Together they form a unique fingerprint.

Cite this